KL and obesity due to melanocortin 4 receptor deficiency: Low α-Klotho levels are associated with insulin resistance and hyperglycemia in obesity and type 2 diabetes, while α-Klotho administration improves glucose homeostasis by enhancing insulin secretion, promoting hepatic glycogen synthesis, and facilitating glucose uptake [14,15,16,17].